DAFALGAN 500 mg, hard capsule 16 capsules, CIP 3400932679041
Brand page: Doliprane, Dafalgan, Efferalgan (paracetamol) — all forms and strengths in France
Active ingredients: Paracetamol
Commercialized according to BDPM
Hard capsule16 capsules, CIP 3400932679041orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DAFALGAN 500 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 16 gélule(s)
- Marketing authorisation holder
- UPSA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 1985
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65609611CIP73267904CIP133400932679041Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLgélule | 500 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.